Transitional formulas (22 kcal/oz) are recommended for infants less than 35 weeks gestation at birth. However, few data are available related to follow-up of infants receiving these formulas who were 28-34 weeks gestation at birth. Primary hypothesis: Provision of supplemental vitamin D to a transitional formula will lead to higher serum 25-hydroxyvitamin D (25-OHD) levels and no infant with a serum 25-OHD less than 20 ng/mL when assessed at approximately 52 weeks post-menstrual age (PMA).
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Enrollment
39
Baylor College of Medicine / Texas Children's Hospital
Houston, Texas, United States
Change from Baseline in Serum 25-hydroxyvitamin D (25-OHD) level at 52 weeks post-menstrual age
Time frame: Last 7 days of hospitalization and at 52 weeks post-menstrual age (PMA)
Change from Baseline in Alkaline phosphatase activity at 52 weeks post-menstrual age
Time frame: Last 7 days of hospitalization and at 52 weeks PMA
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.